Status:
RECRUITING
Evaluation of Virtual Reality to Reduce Anxiety, Pain and Duration of Non-emergency Vigile Bronchial Fibroscopy (AVATAR)
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
Ministry of Health, France
Conditions:
Respiratory Disorder
Lung Infection
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Bronchial fibroscopy (BF) is a routine practice examination in critical care areas. It can be useful either for the diagnosis of the causal pathology of respiratory distress or for the diagnosis of lu...
Detailed Description
Bronchial fibroscopy (BF) is an invasive examination mainly performed in vigilant patients under local anesthesia very regularly performed in patients hospitalized in critical care. Despite local anes...
Eligibility Criteria
Inclusion
- Adults (over 18 years of age)
- Hospitalized in a critical care unit (intensive care and intensive care)
- Conscious (Glasgow score \>13)
- Spontaneous ventilation
- Requiring the realization of a FB
- First BF during hospitalization
- Having signed a consent to participate in the study
- Affiliation to social security
Exclusion
- Non-French-speaking patient
- Protected minors or adults who cannot consent to participate
- People with major neurocognitive impairment
- Patient refusing to participate in the study
- Patient on State medical aid
- Patient under guardianship or curatorship or under judicial protection
- BF for a vital emergency
- Prior inclusion in the study
- Pregnant or breastfeeding women
- Presence of a tracheostomy or tracheostomy
- Participation in other intervention research
- Epilepsy
- Visual impairment (blindness) or severe hearing impairment (hearing loss, deafness) that does not allow the use of the helmet
- Psychiatric pathologies such as delusional disorders, hallucinations or schizophrenia.
- Autism spectrum disorders
- Patient sensitive to motion sickness
- Refractory migraine under treatment
Key Trial Info
Start Date :
October 19 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 26 2025
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT05973201
Start Date
October 19 2023
End Date
October 26 2025
Last Update
December 4 2024
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
CHI Aix en Provence
Aix-en-Provence, France, 13100
2
CHU Dijon
Dijon, France, 21079
3
Hôpital Le Kremlin Bicêtre
Le Kremlin-Bicêtre, France, 94270
4
Hôpital européen Georges Pompidou - AP-HP
Paris, France, 75015